Literature DB >> 1832192

New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent.

B Fisher, C Redmond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1832192     DOI： 10.1093/jnci/83.18.1278

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  13 in total

1.  Overview of new treatments for breast cancer.

Authors:  G N Hortobagyi
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 2.  Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Authors:  Tamara S Dowers; Zhi-Hui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2006-09       Impact factor: 3.739

Review 3.  Suitable trial designs and cohorts for preventive breast cancer agents.

Authors:  Kathrin Strasser-Weippl; Paul E Goss
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

Review 4.  Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.

Authors:  Lori M Minasian; Catherine M Tangen; D Lawrence Wickerham
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

5.  Can breast cancer be prevented?

Authors:  C G Kardinal; J T Cole
Journal:  Ochsner J       Date:  2000-01

6.  Adjuvant treatment with tamoxifen. Side effects may have been overstated.

Authors:  M Baum; J Cuzick
Journal:  BMJ       Date:  1996-04-20

Review 7.  The increasing use of prophylactic mastectomy in the prevention of breast cancer.

Authors:  Todd M Tuttle; Andrea Abbott; Amanda Arrington; Natasha Rueth
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

8.  Phase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue.

Authors:  H Pujol; J Girault; P Rouanet; S Fournier; J Grenier; J Simony; J B Fourtillan; J L Pujol
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer.

Authors:  S P Lehrer; R K Schmutzler; J M Rabin; B S Schachter
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  TREATMENT OF BREAST CANCER: IMO STATE NIGERIA VERSUS INDIANA, USA WOMEN - COMPARATIVE ANALYTIC STUDY.

Authors:  A A Anele; M Bowling; G J Eckert; Elf Gonzalez; H Kipfer; C Sauder
Journal:  J West Afr Coll Surg       Date:  2014 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.